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 Abstract
Aim: Canine lymphoma is one of the most common canine neoplasms, but little is known regarding the effects of exposure 
to tobacco smoke on their biologic behavior. As cytology is the most frequent diagnostic method of canine lymphoma, 
the aims of this study were to perform an immunocytochemical study of canine lymphomas, including subtyping and cell 
proliferation analysis, and to establish their correlation with tobacco smoke exposure.
Materials and Methods: A total of 23 dogs diagnosed with lymphoma were subjected to careful fine-needle biopsies of 
enlarged lymph nodes. The smears were air-dried, fixed with cold acetone, and immunocytochemically stained using CD3, 
PAX5, and Ki-67. Owners were requested to complete an epidemiologic questionnaire.
Results: According to the updated Kiel classification, 65% were B-cell lymphomas - three low grade (LG) and 12 high 
grade (HG) and 35% were T-cell - two LG and six HG. Thirteen tumors presented high Ki67 indexes (>40%) (11 HG and 
2 LG), two revealed moderate ones (20-40%) (1 HG and 1 LG), and three had low indexes (≤20%) (1 HG and 2 LG). 
Both a significant positive correlation and a significant linear-by-linear association (p=0.018) were observed between high 
Ki67 indexes and smoking owners (r=0.753, p=0.002) as well as with the number of smokers in the household (r=0.641, 
p=0.001). Moreover, the mean percentage of Ki67+ cells from the group of “smoker owners” was statically higher (p=0.011) 
than that from the “non-smoker owners.”
Conclusion: The results suggest that cytological diagnosis of canine lymphomas benefits from being complemented with 
immunocytochemical studies that include subtyping and assessment of proliferative activity, both contributing for the 
prognosis and therapeutic planning. Furthermore, exposure to tobacco smoke seems to be related to the biological behavior 
of canine lymphomas.
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Introduction
Lymphomas are a wide and motley group of neo-
plasms which includes several subtypes with distinct 
clinical and epidemiological characteristics [1]. They 
represent one of the most common neoplasms of the 
dog, comprising approximately 7-24% of all neo-
plasms in this species [2]. The increasing frequency 
of canine lymphomas [2,3] mimics a trend in human 
oncology in which non-Hodgkin’s lymphoma (NHL) 
represents 5% of all new cancer cases, currently being 
one of the top five leading cancer-related deaths [4]. 
Dogs and humans are close companions and thus sub-
jected to similar indoor and outdoor environmental 
influences. Therefore, epidemiological studies using 
dogs as sentinels provide an opportunity to assess 
the effects of environmental factors on the biologic 
behavior of cancer [5,6].
Contrary to human medicine, and often due to 
financial constraints, cytology plays a key role in the 
diagnosis of canine lymphoma [3]. The cytological 
analysis is a suitable, easy, and inexpensive diagnostic 
method, which is in agreement with the histological 
classification of most subtypes [3]. According to our 
experience, more than 70% of lymphoma diagnoses 
in dogs are achieved through cytology (unpublished 
data). A recent publication [7] calculated that 90% of 
all canine lymphoma diagnoses were obtained using 
cytology. Although immunocytochemistry (ICC) [8] 
was studied in the past decades, it has not been rou-
tinely included in the diagnostic approach of canine 
lymphomas [9,10].
The updated Kiel classification adapted to 
the canine species [11] is the most frequently used 
classification scheme for the cytological diagnosis 
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of canine lymphomas [9,11-13]. Lymphomas are 
essentially classified on the basis of cell morphol-
ogy and immunological characteristics and subtyped 
according to the fundamental distinction between 
phenotypes (B or T) and malignancy grades (low or 
high) [13]. Such evaluations allow for a 90% accurate 
characterization [5,10,14]. As in human medicine, the 
classification of lymphomas is an important prognos-
tic tool [12,15,16] since, if left untreated, high-grade 
(HG) lymphomas have significantly higher mortality 
rates than low-grade (LG) ones [17]. Yet, the former 
responds better to aggressive chemotherapeutic pro-
tocols, sometimes even achieving complete remis-
sions [18]. There are, however, variations in survival 
rates within similar subtypes and grades, suggesting 
that an individual accurate prognosis may benefit 
from additional evaluations, such as the analysis of 
proliferative activity at the time of diagnosis [9,18].
Epidemiological studies of companion animals 
have been increasing, defining the dog as a sentinel [19] 
of potential risk factors for human health, mainly 
due to shared environments, shorter disease latency, 
and spontaneous diseases as lymphomas [6,20-23]. 
Several environmental and lifestyle factors were asso-
ciated with human NHL [24], and these seem to influ-
ence both the overall and subtypes incidences [1,25]. 
One of these factors is the exposure to cigarette smok-
ing, which represents a risk factor primarily for follic-
ular lymphomas in human patients [26]. Some studies 
have shown different risk factors for the development 
of canine lymphomas such as breed [27], sex and 
hormonal exposure [28], Bartonella infection [29], 
oxidative stress [30], household chemicals [6,31], 
herbicides [32], magnetic fields [33], and air pollu-
tion [5,19-21,34]. It is noteworthy, though, that no 
environmental factors were related to the biological 
behavior of spontaneous canine lymphomas.
Epidemiological data evidenced a correlation 
between tobacco smoking and numerous human can-
cers [35]. Furthermore, new insights emerged regard-
ing second-hand smoking, also named “environmen-
tal tobacco smoke” (ETS), “passive smoking,” or 
“involuntary smoking” [36], as well as third-hand 
smoking (THS) [37]. ETS consists on inhaling both 
the smoke exhaled by smokers and the sidestream 
smoke produced by the burning cigarette that con-
tains the same carcinogenic compounds inhaled 
during active smoking [38]. In addition, when some-
one smokes, several nicotine-like contaminants are 
exhaled and settle down on various household sur-
faces and objects (carpets, table tops, utensils, and 
furniture), remaining there for weeks or months [37]. 
These are later reemitted in a gas phase, reacting with 
oxidants and other environmental compounds, a phe-
nomenon that characterizes the THS [37]. Companion 
animals are undoubtedly second-hand smokers [39], 
and most certainly, third-hand smokers when shar-
ing the household with smoking owners. As “active 
sniffers,” dogs are even more exposed to a wide range 
of potential chemical carcinogens that easily surpass 
the exposure to which human adults or children are 
subjected.
Although human studies suggested a positive 
association between tobacco exposure and the risk of 
follicular NHL [38], veterinary studies on the effects 
of tobacco smoke on lymphomas are inexistent.
The aim of this study was to assess the role of the 
immunocytochemical evaluation of canine lympho-
mas in the improvement of current routine diagnosis. 
Furthermore, another goal was to identify associations 
between exposure to several environmental factors, 
including exposure to tobacco smoke, lymphoma sub-
types, and their biological behavior.
Materials and Methods
Ethical approval
The study was approved by the Bioethics 
Committee of the Institute of Biomedical 
Sciences Abel Salazar of the University of Porto 
(ORBEA-ICBAS-UP).
A prospective series of 23 dogs with a cytolog-
ical diagnosis of lymphoma was considered. From 
each dog, lymph node cytological specimens were col-
lected for diagnostic purposes. Owners were informed 
about the aims and methods of the study and signed an 
informed consent form. Dogs that had received previ-
ous chemotherapy were excluded from the study.
Immunocytochemistry
Fine-needle aspiration biopsies, or just fine-nee-
dle biopsies (FNB), were obtained using a 21-gauge 
needle without aspiration. The material inside the 
needle was immediately smeared using a 10 ml dis-
posable plastic syringe and air-dried. A minimum of 
six smears per enlarged lymph node were produced. 
Submandibular lymph nodes were avoided, when-
ever possible because their drainage of the oral cavity 
consistently yields marked hyperplastic features [40]. 
For diagnostic purposes, a minimum of two smears 
were stained with Hemacolor (Merck, Darmstadt, 
Germany). Lymphoma was diagnosed when the nor-
mal heterogeneous population of lymphocytes was 
replaced by predominantly immature and/or mono-
morphic lymphoid cells [41,42].
For the immunocytochemical assays, smears were 
dried, fixed in cold acetone for 2 min, stored at 2-6°C, 
and processed within 48 h. Immunocytochemical 
stains were conducted with commercially available 
antibodies: The pan T-lymphocyte marker (polyclonal 
rabbit antihuman) CD3 (Dako, Glostrup, Denmark) for 
T-lymphocytes, monoclonal mouse anti-PAX5 anti-
body (Leica Biosystems, Nussloch, Germany) [43] for 
B-lymphocytes, and anti-Ki67 monoclonal antibody 
(MIB-1 mouse) (Dako, Glostrup, Denmark) for pro-
liferation assessment. Immunocytochemical proce-
dures were performed according to the manufacturers’ 
protocols (Novolink Polymer®; Leica Microsystems, 
Nussloch, Germany), using the indirect immunop-
eroxidase staining technique. Heat-induced epitope 
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retrieval was conducted in a hot water bath (100°C, 
23 min) by incubating slides in 10 mM citrated buf-
fer (pH 6.0). The slides were then gradually cooled 
to room temperature. After being washed in 0.05 M 
tris-buffer (pH 7), the slides were incubated with the 
protein block for 5 min. Each section was then incu-
bated for 120 min with primary antibodies diluted 
in 10% bovine serum albumin (Sigma, Darmstadt, 
Germany) (CD3 and Ki67 1:50; PAX5 1:40) at room 
temperature. The endogenous peroxidase activity was 
neutralized using the peroxidase block, and slides were 
then incubated with the second antibody (rabbit anti-
mouse IgG) for 20 min. Diaminobenzidine was used 
as a chromogen, and slides were counterstained with 
Mayer’s hematoxylin. Smears of normal spleen were 
used as positive controls. The percentage of positive 
cells was determined by counting 300 cells at ×400 
magnification in selected fields that showed good cell 
preservation. All cells with the expected staining pat-
tern (membrane/cytoplasmic for CD3 and nuclear for 
PAX-5 and Ki67) were considered positive, regard-
less of the staining intensity. The immunophenotype 
of each lymphoma was based on the most prevalent 
number of positive cells [43]. For the proliferation 
assessment, lymphomas were classified, according to 
the number of positive Ki67 cells, as follows: Low 
index (≤20% Ki67+ cells), moderate index (20-40% 
Ki67+ cells), or high index (>40% Ki67+ cells) as pre-
viously described [15].
Tumors were classified according to the updated 
Kiel classification adapted to the canine species [9], 
based on cell size and shape; cell volume and intensity 
of cytoplasm staining; nuclear size, shape, and posi-
tion; nucleoli size, distinctiveness, number and posi-
tioning; appearance of nuclear chromatin; and mitotic 
indexes (MIs) [44].
Exposure and covariate assessment
Owners were requested to answer a 70-ques-
tion questionnaire about their dog’s demographics, 
health-related characteristics, and environmental 
exposures. Questions regarding the animal included 
age; sex; breed; reproductive status; date and origin of 
acquisition (shelter, breeder, pet shop, stray, or other); 
hair length; nose length; food type; weight; body 
type; grooming care; use of flea/tick control products; 
and physical activity levels. Environmental factors 
included household smoking; house size; use of car-
pets, rugs, and curtains; house location; the amount 
of time the dog spent outdoors; the use of fireplace; 
and exposure to environmental chemicals such as 
herbicides, pesticides, fungicides, rodenticides, and 
cleaning products such as bleach and ammonia. When 
applicable, the questionnaire included exhaustive 
details about exposure to tobacco smoke and its cir-
cumstances, the number of former or current smoking 
cohabitants, the number of daily consumed cigarettes 
(or similar), and the length of smoking time during the 
past decade.
Statistical analysis
Data were analyzed with the Statistical Package 
for the Social Sciences (SPSS), version 24. A pair-
wise comparison with all the collected variables was 
performed, and the significance of the Spearman’s 
rank correlation coefficient was established. The dif-
ference between the average percentage of positive 
Ki67 cells (%Ki67+) in the groups “smoker own-
ers” and “non-smokers owners” was analyzed with 
one-way ANOVA. The linear-by-linear association 
between two levels of smoke exposure and three 
levels of Ki67 - low, moderate, or high, previously 
described - was tested with the Chi-squared test. For 




According to the updated Kiel classification, 
65% (15/23) were B-cell and 35% (8/23) were T-cell 
lymphomas. Eight morphological subtypes were iden-
tified including five B-cell and four T-cell subtypes. 
Out of the B-cell ones, three were LG centroblastic/
centrocytic (Figure-1) and 12 HGs: One centroblastic 
large cell, five centroblastic monomorphic, four cen-
troblastic pleomorphic, and two immunoblastic. Out of 
the eight T-cell lymphomas, two were LG small clear 
cell, and six were HG: One pleomorphic large cell, one 
lymphoblastic, and four pleomorphic mixed (Table-1).
Proliferation assessment
Ki67 ICC was performed in 18 cases with 
well-preserved cytological smears. The mean % Ki67+ 
was 58.1% (standard deviation [SD]=0.28), and the 
median was 54% (range 8-98%). Thirteen lymphomas 
were categorized as high proliferation index (X
_
=0.71; 
SD=0.19), 11 of them being HG ones and two were 
LG. Two lymphomas presented moderate proliferation 
Figure-1: B-cell centroblastic/centrocytic lymphoma of 
a 3-year-old mongrel female dog. Fine-needle aspiration 
biopsies of enlarged pre-scapular lymph node. (a) A 
population of medium-to-large lymphoid cells admixed with 
very few mature lymphocytes Hemacolor, ×400; (b) PAX5 
immunostain (×200); (c) CD3 immunostain (×200); 
(d) Ki67 immunostain - moderate index: 40% (×200).
dc
ba
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indexes (X¯=0.35; SD=0.06), and three cases presented 




The series included seven (30.4%) mongrel 
and 16 (69.6%) purebred dogs (six labrador retriev-
ers - 26%, two boxers - 8.7%, and one each of pointer, 
Portuguese hunting dog, bulldog, cocker spaniel, 
golden retriever, Castro Laboreiro shepherd, and pit 
bull terrier). Eleven dogs (47.8%) were females (45% 
spayed), and 12 (52.2%) were males (8% castrated). 
The mean age was 8.1 years (range, 3-15 years).
The epidemiologic questionnaire was completed 
by all dog owners although only 19 answered the section 
concerning smoking habits (Table-1). The results showed 
that in 11 out of 19 cases (57.89%) either the owners or 
other cohabitants, from 2005 to 2016, were or had been 
active smokers. In seven cases (63.7%), the dog lived 
with one smoker, while in the remaining cases (36.3%), 
there were two smokers cohabiting with the dog.
Pairwise comparison between all studied vari-
ables revealed a statistically significant positive 
correlation (r=0.753, p=0.002) and significant lin-
ear-by-linear association (p=0.018) between the Ki67 
index and smoking status. Data also revealed a statisti-
cally significant positive correlation between the Ki67 
index and the number of smokers who lived with the 
dog (r=0.641, p=0.018). The ANOVA test confirmed 
a significantly different (p=0.011) mean percentage of 
Ki67+ cells between the groups “non-smoker owners” 
(X
_ 
=0.25; SD=0.19) and “smoker owners” (X
_ 
=0.64; 
SD=0.22) (Figure-2). Neither other environmental 
factors nor geographical localization revealed signif-
icant relations with subtype, grade, or tumor prolifer-
ation index.
Discussion
Since lymphomas are a wide group of hemato-
poietic neoplasms with a broad range of potential out-
comes [2,7,16], the simple diagnosis of “lymphoma” 
is of limited value for the clinical management of 
patients or even for the conduction of epidemiological 
studies. ICC plays a unique role in the improvement of 
the cytological diagnosis of canine lymphoma.
As lymphoid tissues lack in cellular cohe-
sion, they permit a rich cellular harvest, so well-ex-
ecuted cytological collection procedures followed 
by adequate processing allow for obtaining useful 
Table-1: Updated Kiel classification, percentage of 
Ki67-positive cells and Ki67 indexes, and household 












Centroblastic 48 High Yes 2
88 High Yes 1
52 High Yes 2
51 High - -
- - Yes 1
- - No 0
31 Moderate Yes 1
89 High - -
95 High - -
- - Yes 2
83 High Yes 1
90 High Yes 1
42 High Yes 1





























40 Moderate No 0
T-cell lymphomas
High-grade
8 Low No 0
87 High Yes 2
61 High Yes 1
56 High No 0
- - No 0
- - No 0

















20 Low No 0
Figure-2: Box-and-whisker diagram depicting the 
percentage of Ki67+ cells categorized by the smoking 
status.   Represents the mean percentage of Ki67+ cells 
per group. Lymphomas affecting dogs owned by smokers 
have a significantly higher mean percentage of Ki67+ cells 
(p<0.05).
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diagnostic information [45]. In our study, FNB was 
performed without suction (the Zajdela or “French” 
technique) [8,46]. Although this technique potentially 
reduces the amount of harvested material, the prepara-
tions are more representative, less contaminated with 
blood and other cells [8] and cells are better preserved, 
which indeed contributes for the quality of immuno-
cytochemical analysis.
Lymphoma cytological subtyping is challeng-
ing, and the use of ICC plays a vital role in both the 
diagnosis and subtyping [8]. Although all lymphoma 
immunophenotyping techniques - immunohistochem-
istry, flow cytometry, and PARR - have their particular 
advantages [8], ICC allows for morphological evalu-
ation of stained cells as well as staining location and 
intensity in a simple smear, thus reducing costs and 
procedures.
MI and Ki67 immunolabeling are the prolifer-
ation parameters more commonly used in veterinary 
oncology [7]. Counting the number of mitotic figures 
in cytological preparations can be misleading and 
lacks representativeness, mainly due to an irregular 
cell distribution [7]. The ICC for Ki67, a non-his-
tone nuclear protein expressed in all stages of the cell 
cycle, may overcome this difficulty and thus improve 
the assessment of the proliferation activity of lympho-
mas. It has been shown that the Ki67 immunolabel-
ing of cytological smears had high concordance with 
Ki67 immunohistochemistry in biopsy tissues [9]. In 
this study, we opted to count 300 cells per tumor, a 
higher number than previously reported (100 cells), to 
ensure the reliability of the results [7,47].
In our series, there was a higher prevalence of 
B-cell (65%) over T-cell lymphomas (35%), and 
56.5% were HG tumors (13/23). Interestingly, Ki67 
index differences were detected within tumors of sim-
ilar grades, both in B- and T-cell lymphomas. There 
was no statistically significant correlation between 
Kiel’s grades and Ki67 indexes or the percentage of 
Ki67-positive cells. Considering that cytotoxic che-
motherapy is the preferred treatment for dogs with 
lymphoma and that it is known that it yields better 
responses in highly proliferating tumors, it is possi-
ble that subtyping and grading fail as prognostic and 
predictive indicators if not complemented with pro-
liferation markers. In human mantle-cell lymphoma, 
the Ki-67 index has already surpassed cytology and 
growth pattern as prognostic factors [48]. Moreover, 
survival time discrepancies within canine lymphoma 
subtypes have already been demonstrated by Ponce 
et al. [12]. In a recent study [15] of HG B-cell lym-
phomas treated with a modified Wisconsin-Madison 
protocol, dogs affected by tumors of intermediate 
Ki67% indexes presented longer survival and relapse-
free intervals than those with low or high Ki67%, as 
determined by flow cytometry. In human medicine, 
Hall et al. [49] analyzed the survival rate of patients 
with different grades and Ki67 indexes, demonstrat-
ing that those affected by LG NHL with high Ki67 
indexes had worse survival rates than those with low 
Ki67 index and that HG NHL with very high Ki67 
indexes had better survival rates when compared to 
those with lower indexes. Therefore, Hoster et al. rec-
ommended that Ki67 index should be routinely esti-
mated in clinical practice to allow for more accurate 
individual risk estimation [48].
Some of the described discrepancies between 
subtypes and proliferation indexes, particularly in the 
LG T-cell small clear subtype with high Ki67 index, 
may be related to the process of transformation. As 
defined by the European canine lymphoma group, 
“transformation is the evolution of an indolent to an 
aggressive lymphoma, typically harboring a very poor 
prognosis” [3]. In veterinary medicine, this phenom-
enon has been undervalued, although it is a possible 
indolent lymphomas’ evolution [50]. To the best of 
authors’ knowledge, however, there were no reports 
confirming the transformation of canine indolent 
lymphomas.
Different factors such as genetic modifications, 
epigenetic transformations, and microenvironmen-
tal conditions may contribute to reprograming and 
transforming the original neoplastic mass into a more 
aggressive one [50,51]. Furthermore, lifestyle factors 
such as smoking habits, obesity, and alcohol consump-
tion have been shown to influence the overall survival 
rate of human NHL patients [52].
The potential links between environmental pol-
lutants and the risk of developing human NHL [24,31] 
and canine lymphomas [6,20,21,53] have been 
described. There is, however, a lack of studies relating 
environmental factors to the biological behavior of 
canine lymphomas, particularly those with potential 
prognostic or predictive value.
In our series, albeit small, a statistically signifi-
cant relationship between exposure to tobacco smoke 
and the lymphomas’ proliferation, as expressed by 
the Ki67 index, emerged. High Ki67 indexes were 
positively correlated with the number of smoker 
cohabitants. These results are consistent with the 
hypothesis that second- and third-hand exposure to 
tobacco smoke could be considered as a hazardous 
factor for dogs with lymphomas by being associ-
ated with enhancement of their proliferative activity 
or transformation. Yet, it should be noted and high-
lighted that larger and more controlled studies are 
warranted to confirm this hypothesis. Given the small 
sample used, the external validity of this study is not 
possible.
Conclusion
In summary, our results suggest that the cyto-
logical diagnosis of canine lymphomas benefits from 
being complemented with immunocytochemical stud-
ies that include subtyping and proliferative assess-
ment, both contributing for the prognosis and the ther-
apeutic planning. Furthermore, exposure to tobacco 
smoke in second- and third-hand ways seems to be 
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related to higher proliferating indexes of canine lym-
phomas, independently of their subtype or grade.
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